美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corium International, Inc.

12.68

0.0000

成交量：- -

成交額：- -

市值：4.63億

市盈率：-8.20

高：12.68

開：12.68

低：12.68

收：12.68

52周最高：13.93

52周最低：7.17

股本：3,651.78萬

流通股本：923.00萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.5461

每股收益(LYR):-1.6440

淨資產收益率：--

總資產收益率：--

市淨率：18.60

市盈率(LYR):-7.71

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Corium International, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.coriumgroup.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Corium International, Inc.於1995年成立於密歇根州，也叫Corium公司並於1996年成為Converting Systems公司。 Corium International是一種商業化階段的生物製藥公司，利用其在透皮和粘膜給藥系統的豐富經驗，專註於開發，製造及專業製藥產品的商業化。再加上Corium International的合作夥伴，該公司已在處方藥和消費市場成功開發出六大銷售產品，而Corium International是為公司的營銷合作夥伴提供產品的唯一商業供應商。這些銷售的產品是可樂定透皮緩釋系統（或TDS ），芬太尼TDS和四個先進的密封白牙產品。Corium International以顯著的機會使用其新穎透皮和粘膜的方法來將新產品推向市場。Corium International的開發平台，使透皮遞送大分子或生物製劑，包括疫苗，肽和蛋白質以及小分子，否則很難以透皮劑的形式傳輸。Corium International的傳遞途徑包括給美國食品和藥物管理局（FDA）的未決藥品營銷應用。此外，Corium International有12個合作夥伴，和在早期階段自籌資金的項目。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CORI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","market":"US","secType":"STK","nameCN":"Corium International, Inc.","latestPrice":12.68,"timestamp":1557518400000,"preClose":12.68,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":9230000,"shares":36517802,"eps":-1.546149,"marketStatus":"停牌","change":0,"latestTime":"03-23 13:15:48 EDT","open":12.68,"high":12.68,"low":12.68,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.546149,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1396497600000,"exchange":"NASDAQ","adjPreClose":12.68,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","floatShares":9230000,"roa":"--","roe":"--","lyrEps":-1.644018,"shares":36517802,"dividePrice":0,"high":12.68,"amplitude":0,"preClose":12.68,"low":12.68,"week52Low":7.17,"pbRate":"18.60","week52High":13.93,"institutionHeld":0,"latestPrice":12.68,"eps":-1.546149,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.546149,"open":12.68,"prevYearClose":12.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-08-09","symbol":"CORI","fiscalQuarterEnding":"2018/06","expectedEps":-0.39,"name":null,"time":"盤後","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2018-05-14","symbol":"CORI","fiscalQuarterEnding":"2018/03","expectedEps":-0.41,"name":null,"time":"盤後","type":"earning","dateTimestamp":1526270400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2018-02-08","symbol":"CORI","fiscalQuarterEnding":"2017/12","expectedEps":-0.43,"name":null,"time":"盤後","type":"earning","dateTimestamp":1518066000000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2017-11-16","symbol":"CORI","fiscalQuarterEnding":"2017/09","expectedEps":-0.43,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510808400000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2017-08-03","symbol":"CORI","fiscalQuarterEnding":"2017/06","expectedEps":-0.3,"name":null,"time":"盤後","type":"earning","dateTimestamp":1501732800000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.coriumgroup.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Corium International, Inc.於1995年成立於密歇根州，也叫Corium公司並於1996年成為Converting Systems公司。 Corium International是一種商業化階段的生物製藥公司，利用其在透皮和粘膜給藥系統的豐富經驗，專註於開發，製造及專業製藥產品的商業化。再加上Corium International的合作夥伴，該公司已在處方藥和消費市場成功開發出六大銷售產品，而Corium International是為公司的營銷合作夥伴提供產品的唯一商業供應商。這些銷售的產品是可樂定透皮緩釋系統 （或TDS ），芬太尼TDS和四個先進的密封白牙產品。Corium International以顯著的機會使用其新穎透皮和粘膜的方法來將新產品推向市場。Corium International的開發平台，使透皮遞送大分子或生物製劑，包括疫苗，肽和蛋白質以及小分子，否則很難以透皮劑的形式傳輸。Corium International的傳遞途徑包括給美國食品和藥物管理局（FDA）的未決藥品營銷應用。此外，Corium International有12個合作夥伴，和在早期階段自籌資金的項目。","exchange":"NASDAQ","name":"Corium International, Inc.","nameEN":"Corium"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":null}}